Dr. Tsai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-1000
Education & Training
- University of California San Francisco School of MedicineFellowship, 2013 - 2015
- University of North Carolina HospitalsResidency, 2010 - 2013
- The Warren Alpert Medical School of Brown UniversityClass of 2010
Certifications & Licensure
- CA State Medical License 2013 - 2026
- NC State Medical License 2010 - 2013
Publications & Presentations
PubMed
- Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.Zoe Quandt, Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah, Chaorong Wu, Clinton Wu
BJC Reports. 2024-06-24 - 4 citationsNCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.Susan M Swetter, Douglas Johnson, Mark R Albertini, Christopher A Barker, Sarah Bateni
Journal of the National Comprehensive Cancer Network. 2024-07-01 - 63 citationsSingle-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment.Kristen E. Pauken, Osmaan Shahid, Kaitlyn A. Lagattuta, Kelly M. Mahuron, Jacob M. Luber
The Journal of Experimental Medicine. 2021-04-05
Press Mentions
- What People of Color Need to Know About Sun Protection and Skin CancerAugust 16th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: